Pages that link to "Q51548249"
Jump to navigation
Jump to search
The following pages link to Radioligand binding and immunoautoradiographic evidence for a lack of toxicity to dopaminergic nerve terminals in human cocaine overdose victims. (Q51548249):
Displaying 16 items.
- Decreased expression of the transcription factor NURR1 in dopamine neurons of cocaine abusers (Q24534267) (← links)
- The neurocircuitry of illicit psychostimulant addiction: acute and chronic effects in humans (Q28236333) (← links)
- Proton magnetic resonance spectroscopy of human basal ganglia: response to cocaine administration (Q30617004) (← links)
- Excited delirium (Q34194245) (← links)
- Decreased vesicular monoamine transporter type 2 availability in the striatum following chronic cocaine self-administration in nonhuman primates (Q34765909) (← links)
- Impact of psychostimulants on vesicular monoamine transporter function (Q35581553) (← links)
- In vivo evidence for low striatal vesicular monoamine transporter 2 (VMAT2) availability in cocaine abusers (Q36118252) (← links)
- PACAP38 increases vesicular monoamine transporter 2 (VMAT2) expression and attenuates methamphetamine toxicity. (Q36942673) (← links)
- Medication discovery for addiction: translating the dopamine D3 receptor hypothesis (Q37331530) (← links)
- 2C or not 2C: phenethylamine designer drug review. (Q38089682) (← links)
- Common human 5' dopamine transporter (SLC6A3) haplotypes yield varying expression levels in vivo (Q42495616) (← links)
- Incidence of Parkinson's disease among hospital patients with methamphetamine‐use disorders (Q42926652) (← links)
- Cognitive performance by humans during a smoked cocaine binge-abstinence cycle. (Q46829636) (← links)
- Cocaine, but not amphetamine, short term treatment elevates the density of rat brain vesicular monoamine transporter 2. (Q48451590) (← links)
- Polymer-encapsulated PC-12 cells demonstrate high-affinity uptake of dopamine in vitro and 18F-Dopa uptake and metabolism after intracerebral implantation in nonhuman primates (Q48618232) (← links)
- Reserpine or chronic paroxetine treatments do not modify the vesicular monoamine transporter 2 expression in serotonin-containing regions of the rat brain (Q73571957) (← links)